Prodrugs and Targeted Delivery: Towards Better ADME Properties (Google eBook)
John Wiley & Sons, Jan 11, 2011 - Medical - 520 pages
This topical reference and handbook addresses the chemistry, pharmacology, toxicology and the patentability of prodrugs, perfectly mirroring the integrated approach prevalent in today's drug design. It summarizes current experiences and strategies for the rational design of prodrugs, beginning at the early stages of the development process, as well as discussing organ- and site-selective prodrugs.
Every company employing medicinal chemists will be interested in this practice-oriented overview of a key strategy in modern drug discovery and development.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Antitargets: Prediction and Prevention of Drug Side Effects
Roy Vaz,Thomas Klabunde
Limited preview - 2008
Other editions - View all
absorption active drug acyclovir adefovir agents alkyl amine amino acid aqueous solubility barrier bioavailability biological brain Cancer Research capecitabine carboxylesterase carboxylic acid cells chemical clinical clopidogrel codrug coefﬁcient compounds conjugates cytochrome P450 cytotoxic dose drug delivery drug discovery Drug Metabolism effects efﬁcacy efﬂux enhanced enterocytes enzymatic enzyme enzyme prodrug therapy esmolol ester ester prodrug esterases example Figure ﬁrst ﬂux formulation fosphenytoin functional groups ganciclovir gastrointestinal GDEPT gene therapy human hydrolysis inhibitor intestine ionized irinotecan Journal of Medicinal Journal of Pharmaceutical linker lipophilic liver Medicinal Chemistry membrane metabolite modiﬁcation moiety Molecular molecule mustard ocular oral bioavailability parent drug PEPT1 peptide permeability permeation Pharmaceutical Sciences pharmacokinetics phosphate plasma polymorphisms potential prodrug prodrug approach prodrug design prodrug strategies proﬁle promoiety properties receptor release signiﬁcant signiﬁcantly soft drug speciﬁc studies substrate systemic tamoxifen target therapeutic tissue toxicity transport treatment tumor vector vitro vivo ximelagatran